Pluri Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent
Pluri Inc. (PLUR) reported Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent of 6.00% for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign · last filed 2025-09-17
- Pluri Inc. effective income tax rate reconciliation, tax credit, foreign, percent for fiscal 2025 was 6.00%, a 0.00% change from fiscal 2024.
- Pluri Inc. effective income tax rate reconciliation, tax credit, foreign, percent for fiscal 2024 was 6.00%.
- Pluri Inc. effective income tax rate reconciliation, tax credit, foreign, percent for fiscal 2020 was 6.00%, a 0.00% change from fiscal 2019.
- Pluri Inc. effective income tax rate reconciliation, tax credit, foreign, percent for fiscal 2019 was 6.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent 12 month |
|---|---|
| 2025-06-30 | 6.00% 10-K · filed 2025-09-17 |
| 2024-06-30 | 6.00% 10-K · filed 2024-09-18 |
| 2020-06-30 | 6.00% 10-K · filed 2020-09-10 |
| 2019-06-30 | 6.00% 10-K · filed 2019-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |